Works matching IS 17407745 AND DT 2013 AND VI 10 AND IP 1
Results: 25
Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. S5, doi. 10.1177/1740774512440342
- By:
- Publication type:
- Article
Commentary on ‘Small-sample behavior of novel phase I cancer trial designs’.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Discussion of ‘Small-sample behavior of novel phase I cancer trial designs’ by Assaf P Oron and Peter D Hoff.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Cost–utility analysis conducted alongside randomized controlled trials: Are economic end points considered in sample size calculations and does it matter?
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Unblinding following trial participation: Qualitative study of participants’ perspectives.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
2012 Peer Reviewers.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 188, doi. 10.1177/1740774513475407
- Publication type:
- Article
Small-sample behavior of novel phase I designs: Rejoinder.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 88, doi. 10.1177/1740774512470766
- By:
- Publication type:
- Article
Commentary on ‘Small-sample behavior of novel phase I cancer trial designs’.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 86, doi. 10.1177/1740774512470221
- By:
- Publication type:
- Article
Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 54, doi. 10.1177/1740774512467404
- By:
- Publication type:
- Article
Discussion of ‘Small-sample behavior of novel phase I cancer trial designs’ by Assaf P Oron and Peter D Hoff.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 81, doi. 10.1177/1740774512469313
- By:
- Publication type:
- Article
Small-sample behavior of novel phase I cancer trial designs.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 63, doi. 10.1177/1740774512469311
- By:
- Publication type:
- Article
A systematic review of on-site monitoring methods for health-care randomised controlled trials.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 104, doi. 10.1177/1740774512467405
- By:
- Publication type:
- Article
Clinician-trialist rounds: 14. Ways to advance your career by saying ‘no’ – part 2: When to say ‘no’, and why.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 181, doi. 10.1177/1740774512467238
- By:
- Publication type:
- Article
Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 170, doi. 10.1177/1740774512467237
- By:
- Publication type:
- Article
Using scratch card technology for random allocation concealment in a clinical trial with a crossover design.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 125, doi. 10.1177/1740774512465496
- By:
- Publication type:
- Article
Meta-analysis of clinical trial safety data in a drug development program: Answers to frequently asked questions.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 20, doi. 10.1177/1740774512465495
- By:
- Publication type:
- Article
Cost–utility analysis conducted alongside randomized controlled trials: Are economic end points considered in sample size calculations and does it matter?
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 43, doi. 10.1177/1740774512465358
- By:
- Publication type:
- Article
Accrual by groups in trials with discrete-time survival endpoints.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 32, doi. 10.1177/1740774512464831
- By:
- Publication type:
- Article
Obtaining surrogate consent for a minimal-risk research study in the intensive care unit setting.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 93, doi. 10.1177/1740774512464727
- By:
- Publication type:
- Article
Unblinding following trial participation: Qualitative study of participants’ perspectives.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 97, doi. 10.1177/1740774512464726
- By:
- Publication type:
- Article
Bayesian adaptive design for device surveillance.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 5, doi. 10.1177/1740774512464725
- By:
- Publication type:
- Article
Usefulness of prestudy assessment of patient willingness to undergo tissue biopsy for correlative studies in a melanoma vaccine trial.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 143, doi. 10.1177/1740774512464438
- By:
- Publication type:
- Article
Conducting the ACTIVE randomized trial in hospice care: Keys to success.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 160, doi. 10.1177/1740774512461858
- By:
- Publication type:
- Article
Moving a randomized clinical trial into an observational cohort.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 131, doi. 10.1177/1740774512460345
- By:
- Publication type:
- Article
Efficiency of using community organisations as catalysts for recruitment to continence promotion trials.
- Published in:
- Clinical Trials, 2013, v. 10, n. 1, p. 151, doi. 10.1177/1740774512460144
- By:
- Publication type:
- Article